These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 1907703)

  • 1. [Too little health care for invested money. Estimation of costs of coronary angiography].
    Szamosi A
    Lakartidningen; 1991 Jul; 88(30-31):2534-6. PubMed ID: 1907703
    [No Abstract]   [Full Text] [Related]  

  • 2. The pre-test risk stratified cost-effectiveness of 64-slice computed tomography coronary angiography in the detection of significant obstructive coronary artery disease in patients otherwise referred to invasive coronary angiography.
    Kreisz FP; Merlin T; Moss J; Atherton J; Hiller JE; Gericke CA
    Heart Lung Circ; 2009 Jun; 18(3):200-7. PubMed ID: 19250870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ambulatory angiography saves money and shortens waiting time].
    Haglind E; Lundholm K
    Lakartidningen; 1991 Jun; 88(26-27):2380-1. PubMed ID: 1906964
    [No Abstract]   [Full Text] [Related]  

  • 4. Saving time, saving money: a time and motion study with contrast management systems.
    Lehmann C; Hotaling M
    J Invasive Cardiol; 2005 Feb; 17(2):118-21; quiz 122. PubMed ID: 15687541
    [No Abstract]   [Full Text] [Related]  

  • 5. The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden.
    Lindgren P; Stenestrand U; Malmberg K; Jönsson B
    Clin Ther; 2005 Jan; 27(1):100-10. PubMed ID: 15763611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of clopidogrel in acute coronary syndromes in Sweden: a long-term model based on the CURE trial.
    Lindgren P; Jönsson B; Yusuf S
    J Intern Med; 2004 May; 255(5):562-70. PubMed ID: 15078498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Child health services in the USA respective Sweden. A comparison does not support cost savings in Sweden].
    Jerdén L
    Lakartidningen; 1996 Jun; 93(25):2406-7. PubMed ID: 8684049
    [No Abstract]   [Full Text] [Related]  

  • 8. Contrast media cost analysis--I.
    Zbrozek AS
    J Am Coll Cardiol; 1994 Mar; 23(3):826; author reply 827-8. PubMed ID: 8113571
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost of radiotherapy in Sweden.
    Acta Oncol; 1996; 35 Suppl 6():57-71. PubMed ID: 9154086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast media cost analysis--II.
    Olukotun AY
    J Am Coll Cardiol; 1994 Mar; 23(3):826-7; author reply 827-8. PubMed ID: 8113572
    [No Abstract]   [Full Text] [Related]  

  • 11. A measure of 2 x 2 association with stable variance and approximately normal small-sample distribution: planning cost-effective studies.
    Kraemer HC
    Biometrics; 1986 Jun; 42(2):359-70. PubMed ID: 3091109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemodynamics studies with the new generation portable systems: cost-benefit analysis].
    Vergara G
    Ital Heart J Suppl; 2001 Jan; 2(1):22-5. PubMed ID: 11216079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of combined coronary angioplasty and coronary angiography].
    Fonseca E; Le Feuvre C; Helft G; Beygui F; Zérah T; Dambrin G; Batisse JP; Catuli D; Vacheron A; Metzger JP
    Arch Mal Coeur Vaiss; 2002 Oct; 95(10):891-6. PubMed ID: 12462898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of memantine for moderate to severe Alzheimer's disease in Sweden.
    Jönsson L
    Am J Geriatr Pharmacother; 2005 Jun; 3(2):77-86. PubMed ID: 16129384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacoeconomic evaluation of aggressive cholesterol lowering in Sweden.
    Olsson A; Casciano R; Stern L; Svangren P
    Int J Cardiol; 2004 Jul; 96(1):51-7. PubMed ID: 15203261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of prevention: economic aspects.
    Jönsson B
    Ciba Found Symp; 1985; 110():22-37. PubMed ID: 3921320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives.
    Navas E; Salleras L; Domínguez A; Ibáñez D; Prat A; Sentís J; Garrido P
    Vaccine; 2007 Apr; 25(16):3233-9. PubMed ID: 17324489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Decisions by the state, county council's money and my patient. Consequences of the LFN survey of antihypertensive agents].
    André M; Andersén-Karlsson E; Landahl S; Löfmark R; Silfverhielm B; Skoglund I
    Lakartidningen; 2008 May 21-27; 105(21):1549-50. PubMed ID: 18574990
    [No Abstract]   [Full Text] [Related]  

  • 19. A multicentre, retrospective study of resource utilization and costs associated with glaucoma management in France and Sweden.
    Lindblom B; Nordmann JP; Sellem E; Chen E; Gold R; Polland W; Williamson W; Buchholz P; Walt JG; Groleau D; Curry A; Evans SJ
    Acta Ophthalmol Scand; 2006 Feb; 84(1):74-83. PubMed ID: 16445443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs of an early intervention versus a conservative strategy in acute coronary syndrome.
    Epstein DM; Sculpher MJ; Clayton TC; Henderson RA; Pocock SJ; Buxton MJ; Fox KA
    Int J Cardiol; 2008 Jul; 127(2):240-6. PubMed ID: 17707103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.